ATE484591T1 - Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression - Google Patents

Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression

Info

Publication number
ATE484591T1
ATE484591T1 AT04791263T AT04791263T ATE484591T1 AT E484591 T1 ATE484591 T1 AT E484591T1 AT 04791263 T AT04791263 T AT 04791263T AT 04791263 T AT04791263 T AT 04791263T AT E484591 T1 ATE484591 T1 AT E484591T1
Authority
AT
Austria
Prior art keywords
dna sequence
protein expression
chromatin insulator
minimal dna
sequence acting
Prior art date
Application number
AT04791263T
Other languages
English (en)
Inventor
Philippe Chatellard
Markus Imhof
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Application granted granted Critical
Publication of ATE484591T1 publication Critical patent/ATE484591T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04791263T 2003-10-21 2004-10-20 Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression ATE484591T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03103890 2003-10-21
PCT/EP2004/052591 WO2005040384A1 (en) 2003-10-21 2004-10-20 Minimal dna sequence acting as a chromatin insulator and its use in protein expression

Publications (1)

Publication Number Publication Date
ATE484591T1 true ATE484591T1 (de) 2010-10-15

Family

ID=34486337

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04791263T ATE484591T1 (de) 2003-10-21 2004-10-20 Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein- expression

Country Status (17)

Country Link
US (1) US8133699B2 (de)
EP (1) EP1675956B1 (de)
JP (1) JP4745972B2 (de)
AT (1) ATE484591T1 (de)
AU (1) AU2004284243B2 (de)
CA (1) CA2541523A1 (de)
CY (1) CY1110868T1 (de)
DE (1) DE602004029598D1 (de)
DK (1) DK1675956T3 (de)
ES (1) ES2354160T3 (de)
HR (1) HRP20100560T1 (de)
IL (1) IL175021A (de)
NO (1) NO338767B1 (de)
PL (1) PL1675956T3 (de)
PT (1) PT1675956E (de)
SI (1) SI1675956T1 (de)
WO (1) WO2005040384A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1395669B1 (de) 2001-01-26 2009-07-22 Selexis S.A. Matrix-anheftungsregionen und verfahren zu deren verwendung
ATE399872T1 (de) * 2003-03-11 2008-07-15 Serono Lab Expressionvektoren, die den promotor des ie2-gens des maus cytomegalovirus enthalten
DK1622939T3 (da) * 2003-05-13 2012-04-10 Merck Serono Sa Aktive varianter af det IL-18-bindende protein og medicinske anvendelser deraf
PL1959011T3 (pl) 2003-10-24 2012-07-31 Selexis Sa Wysokowydajny transfer genu i ekspresja w komórkach ssaczych przez procedurę wielokrotnej transfekcji sekwencji regionu przylegania do macierzy
ES2285543T3 (es) * 2003-11-05 2007-11-16 Ares Trading S.A. Procedimiento para la purificacion de la proteina de union a il-18.
DE602005002829T2 (de) * 2004-03-01 2008-07-10 Ares Trading S.A. Verwendung eines serumfreien zellkulturmediums zur produktion von il-18bp in säugerzellen
AU2005259269B2 (en) * 2004-06-29 2010-12-09 Ares Trading S.A. Process for the purification of IL-18 binding protein
ES2385639T3 (es) * 2005-06-03 2012-07-27 Ares Trading S.A. Producción de una proteína de unión a IL-18 recombinante
AU2006256763B2 (en) * 2005-06-10 2012-08-02 Ares Trading S.A. Process for the purification of IL-18 binding protein
EP1760092A1 (de) * 2005-08-26 2007-03-07 Applied Research Systems ARS Holding N.V. System für Screening von Zellen mit hoher Expression von einem interessierenden Protein
FR2919616A1 (fr) * 2007-08-02 2009-02-06 Ecole Norm Superieure Lyon Polynucleotides insulateurs derives de l'element d4z4 et leurs utilisations en transgenese
EP2697375B1 (de) 2011-04-13 2017-10-18 National Research Council of Canada Expressionssystem mit einem kerngerüst-anheftungsregions-element aus interferon 2
CA2857755A1 (en) * 2011-12-21 2013-06-27 Danisco Us Inc. Improving fungal gene expression using insulator dna sequences
KR102055438B1 (ko) 2012-07-31 2019-12-19 에이지엑스 쎄라퓨틱스, 인크. Hla g-변형된 세포 및 방법
KR101591823B1 (ko) * 2013-12-27 2016-02-04 재단법인 목암생명공학연구소 증가된 유전자 발현능을 갖는 발현벡터
US11246896B2 (en) 2015-10-28 2022-02-15 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Tumor-specific adenovirus vectors and therapeutic uses
CN115141836B (zh) * 2015-10-28 2024-08-27 桑格摩生物治疗股份有限公司 肝特异性构建体、因子viii表达盒及其使用方法
AU2017290389B2 (en) 2016-07-01 2024-09-26 Resolve Therapeutics, Llc Optimized binuclease fusions and methods
CN106754817B (zh) * 2016-11-03 2021-02-05 山西省生物研究院有限公司 一种重组自分泌运动因子的表达方法
US10947295B2 (en) 2017-08-22 2021-03-16 Sanabio, Llc Heterodimers of soluble interferon receptors and uses thereof
CA3100946A1 (en) 2018-05-22 2019-11-28 The Brigham And Women's Hospital, Inc. Gene therapy for alzheimer's disease
EP3829650A4 (de) 2018-08-03 2022-05-04 Sangamo Therapeutics, Inc. Verbesserte klinische parameter durch expression von faktor viii
EP3976637A4 (de) 2019-05-24 2023-07-12 The Brigham and Women's Hospital, Inc. Gentherapie für morbus alzheimer
KR20220108096A (ko) * 2019-11-29 2022-08-02 파로스 바이오, 인코포레이티드 신경퇴행성 질환에 대한 유전자 요법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859205A (en) * 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
US6113898A (en) * 1995-06-07 2000-09-05 Idec Pharmaceuticals Corporation Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies
US6432700B1 (en) * 1997-03-03 2002-08-13 Cell Genesys, Inc. Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
US6194152B1 (en) * 1997-08-20 2001-02-27 Dendreon Corporation Prostate tumor polynucleotide compositions and methods of detection thereof
AU1128400A (en) * 1998-10-22 2000-05-08 Medical College Of Georgia Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
JP2003504016A (ja) 1999-06-30 2003-02-04 アメリカ合衆国 遺伝子発現の制御のための特異的エンハンサー遮断活性を有する絶縁体としてのdna結合タンパク質および配列
ATE399872T1 (de) 2003-03-11 2008-07-15 Serono Lab Expressionvektoren, die den promotor des ie2-gens des maus cytomegalovirus enthalten
DK1622939T3 (da) 2003-05-13 2012-04-10 Merck Serono Sa Aktive varianter af det IL-18-bindende protein og medicinske anvendelser deraf
ES2285543T3 (es) 2003-11-05 2007-11-16 Ares Trading S.A. Procedimiento para la purificacion de la proteina de union a il-18.
DE602005002829T2 (de) 2004-03-01 2008-07-10 Ares Trading S.A. Verwendung eines serumfreien zellkulturmediums zur produktion von il-18bp in säugerzellen
AU2005259269B2 (en) 2004-06-29 2010-12-09 Ares Trading S.A. Process for the purification of IL-18 binding protein
ES2385639T3 (es) 2005-06-03 2012-07-27 Ares Trading S.A. Producción de una proteína de unión a IL-18 recombinante
AU2006256763B2 (en) 2005-06-10 2012-08-02 Ares Trading S.A. Process for the purification of IL-18 binding protein

Also Published As

Publication number Publication date
NO338767B1 (no) 2016-10-17
US8133699B2 (en) 2012-03-13
PL1675956T3 (pl) 2011-06-30
WO2005040384A1 (en) 2005-05-06
NO20062315L (no) 2006-07-18
CY1110868T1 (el) 2015-06-10
DK1675956T3 (da) 2010-11-22
EP1675956B1 (de) 2010-10-13
JP2007508833A (ja) 2007-04-12
US20070134761A1 (en) 2007-06-14
AU2004284243A1 (en) 2005-05-06
PT1675956E (pt) 2010-11-04
EP1675956A1 (de) 2006-07-05
SI1675956T1 (sl) 2010-12-31
CA2541523A1 (en) 2005-05-06
IL175021A0 (en) 2006-08-20
DE602004029598D1 (de) 2010-11-25
AU2004284243B2 (en) 2010-11-04
JP4745972B2 (ja) 2011-08-10
IL175021A (en) 2011-07-31
HRP20100560T1 (hr) 2010-11-30
ES2354160T3 (es) 2011-03-10

Similar Documents

Publication Publication Date Title
DE602004029598D1 (de) Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein-expression
DK1697523T3 (da) Ekspressionsvektor til antibiotikafri ekspression
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
ATE342917T1 (de) Antimikrobielle polypeptide aus pseudoplectania nigrella
ATE512980T1 (de) Polypeptide mit beta-glucosidase-aktivität sowie diese codierende polynukleotide
ATE310090T1 (de) Gereinigte coprinus laccasen und nukleinsäuren welche dafür kodieren
ATE454393T1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
ATE492633T1 (de) Polypeptide mit cellobiohydrolaseaktivität und dafür kodierende polynukleotide
ATE503009T1 (de) Polypeptide mit lipase-aktivität und diese kodierende polynukleotide
ATE323770T1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
DE60325611D1 (de) Benzoat- und antranilatinduzierbare promotoren
EA200401453A1 (ru) Молекулы распознавания на клеточной поверхности, содержащие иммуноглобулиновый домен
ATE384787T1 (de) Tripeptidyl-aminopeptidase
ATE362544T1 (de) Polypeptide mit alpha-h alpha amino acid amide racemase aktivitität und nukleinsäuren kodierend dafür
ATE532861T1 (de) Expressionsvektor
DK0724637T4 (da) Kortikotropinfrigørende faktor2-receptorer
ATE387220T1 (de) Nukleinsäuren, polypeptide und verfahren zur modulierung von apoptosis
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
ATE442445T1 (de) Rhamnose-induzierbares expressionssystem
TW200510460A (en) Antimicrobial polypeptides
ZA200610470B (en) Novel sequence for improving expression of nucleic acid
DK1756273T3 (da) Signalpeptid til frembringelse af et polypeptid
ATE449107T1 (de) Aus fisch gewonnene peptide und nukleinsäuren der cathelicidin familie und deren verwendung
AU2003227622A1 (en) Methylthiophene carboxanilides
DE502004009150D1 (de) Neuer endospermspezifischer pflanzenpromotor für kulturpflanzen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1675956

Country of ref document: EP